Walmart Inc (WMT) opened down by 8.78%. The Food & Drug Retailing sector is down by 7.16%. The company underperformed the industry. Top 3 stocks by turnover in the sector: Walmart Inc (WMT) down 8.78%; Kroger Co (KR) down 0.55%; Sysco Corp (SYY) up 2.18%.

What is driving Walmart Inc (WMT)’s stock price down today?

Walmart experienced a sharp downward movement following its second-quarter fiscal 2027 financial results announcement. Although the retail giant reported quarterly revenue and adjusted earnings per share that surpassed Wall Street consensus expectations, investor attention shifted toward deceleration in core domestic metrics. A major catalyst behind the selling pressure was lower-than-anticipated U.S. same-store sales growth, marking a significant slowdown from prior periods. The drag on domestic comparable store sales was largely attributed to pricing adjustments and regulatory headwinds in the health and wellness segment, specifically stemming from Medicare drug pricing reforms.

In addition to soft domestic store performance, market sentiment was further dampened by conservative forward-looking commentary. Management issued third-quarter revenue and profit guidance that fell below consensus forecasts, signaling potential near-term growth constraints and consumer spending caution. This outlook amplified pre-existing investor concerns regarding the stock's elevated valuation, especially following a pre-earnings downgrade from Wall Street analysts who warned of limited upside and margin pressures in the pharmacy category.

Ultimately, while Walmart demonstrated continued expansion in higher-margin segments like global e-commerce and advertising, market participants prioritized the softer domestic comparable sales trend and cautious forward guidance. The reaction reflects an institutional portfolio recalibration, as investors adjusted positioning to reflect potential short-term operational hurdles and a recalibration of multi-quarter valuation expectations.

Technical Analysis of Walmart Inc (WMT)

Technically, Walmart Inc (WMT) shows a MACD (12,26,9) value of -0.502, indicating a sell signal. The RSI at 30.689 suggests neutral condition and the Williams %R at 98.284 suggests oversold condition. Please monitor closely.

Media Coverage of Walmart Inc (WMT)

In terms of media coverage, Walmart Inc (WMT) shows a coverage score of 50, indicating a moderate level of media attention. The overall market sentiment index is currently in bullish zone.

Fundamental Analysis of Walmart Inc (WMT)

Walmart Inc (WMT) is in the Food & Drug Retailing industry. Its latest annual revenue is $713.16B, ranking 1 in the industry. The net profit is $21.89B, ranking 1 in the industry. Company Profile

Over the past month, multiple analysts have rated the company as Buy, with an average price target of $138.04, a high of $155.00, and a low of $72.45.

More details about Walmart Inc (WMT)

Company Specific Risks:

• Weak Q3 Outlook and Guidance Miss: Despite beating second-quarter expectations, Walmart issued cautious Q3 EPS guidance of $0.62 to $0.64 on sales growth of 3% to 3.5%, missing Wall Street consensus forecasts of $0.68 per share and $188.19 billion in sales due in part to a timing shift in Flipkart's annual flagship promotional event.
• Deceleration in U.S. Same-Store Sales Growth: Second-quarter U.S. comparable store sales grew by only 2.6%, marking a sharp slowdown from 4.1% in the prior quarter and representing the company's lowest same-store sales growth rate in six years as consumer spending on non-essential goods moderates.
• Pharmaceutical Regulatory and Price-Cap Margin Drag: Walmart's pharmacy and wellness unit experienced revenue and margin compression resulting from federal Medicare drug-price regulation under the Inflation Reduction Act, which caps prescription drug prices and creates a structural drag on store-level comps.
• Elevated Valuation Multiples and Analyst Downgrades: Trading at a rich forward price-to-earnings multiple near 40x prior to the release, Walmart faced institutional downgrades flagging valuation risks and near-term margin headwinds, leaving the stock vulnerable to sharp profit-taking when quarterly metrics underperform.

Find out more